Towards Healthcare
HIV Clinical Trials Market to Reach USD 2.54 Bn by 2034

HIV Clinical Trials Market Boosted by Advancing Vaccine Trials

Projections indicate that, the global HIV clinical trials market will increase from USD 1.27 billion in 2024 to USD 2.54 billion by 2034, experiencing a CAGR of 7.17% over the next 10 years. The HIV clinical trials market is expanding due to growing research and development, as well as rising HIV vaccine development. North America led the market due to the presence of a well-developed research and development infrastructure.

Content

  • Insight Code: 6127
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The HIV clinical trials market in 2025 is valued at USD 1.36 billion and is projected to climb to USD 2.54 billion by 2034, with a CAGR of 7.17% over the forecast period.

North America is currently leading the HIV clinical trials market due to the presence of advanced research and development infrastructure.

The HIV clinical trials market includes four segments such as by trial phase, by therapeutic modality/intervention type, by sponsor type, and by region.

HIV clinical trials focus on all clinical research activities conducted to discover, develop, evaluate, and validate therapies, prevention strategies, vaccines, diagnostics/biomarkers, and potential cures for Human Immunodeficiency Virus (HIV).

The growing demand for preventive or curative options drives the HIV clinical trials market growth.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions